Page results
-
UCLH chair Baroness Julia Neuberger has today announced that Professor Marcel Levi will be stepping down from his role as UCLH chief executive on 31 March 2021.
-
UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.
-
The UCLH@Home service is helping patients like 80-year-old Margaret Stone to continue their recovery in their own home under the care of their hospital team.
-
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
-
UCLH has moved one step closer to carbon net zero emissions with the installation of six new mobile Entonox destructions units across our birthing centre and labour wards.
-
On Wednesday 29th March, governors Mick Goss and Fiona McLean arranged for governors to visit the National Hospital for Neurology and Neurosurgery (NHNN) at Queen Square.
-
The research team said the placenta acted as a barrier to transmission.
-
We have been incredibly saddened to have had seven members of staff lose their lives to COVID-19.
File results
-
FOI/2022/0551 - Procurement contact details
-
FOI/2022/0555 - Senior staff contact details
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0542 - Infection control audits from September 2020 to April 2021
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0559 - Proton Beam Therapy contract
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology